CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860103. A total of 41 filers reported holding CLEVELAND BIOLABS INC in Q4 2013. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $27,000 | +440.0% | 93,326 | +804.4% | 0.00% | – |
Q3 2014 | $5,000 | 0.0% | 10,319 | -2.4% | 0.00% | – |
Q2 2014 | $5,000 | -82.1% | 10,571 | -74.3% | 0.00% | – |
Q1 2014 | $28,000 | -58.8% | 41,096 | -29.6% | 0.00% | -100.0% |
Q4 2013 | $68,000 | +195.7% | 58,380 | +288.0% | 0.00% | – |
Q3 2013 | $23,000 | – | 15,045 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 697,300 | $1,102,000 | 0.26% |
GOODNOW INVESTMENT GROUP, LLC | 601,889 | $951,000 | 0.17% |
MACROVIEW INVESTMENT MANAGEMENT LLC | 38,000 | $60,000 | 0.06% |
BHR Capital LLC | 300,000 | $474,000 | 0.05% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 746,200 | $1,172,000 | 0.04% |
PRELUDE CAPITAL MANAGEMENT, LLC | 67,200 | $106,000 | 0.02% |
Van Cleef Asset Management,Inc | 20,000 | $32,000 | 0.02% |
RICE HALL JAMES & ASSOCIATES, LLC | 69,981 | $111,000 | 0.01% |
KINGS POINT CAPITAL MANAGEMENT | 10,000 | $16,000 | 0.01% |
TAURUS ASSET MANAGEMENT, LLC | 15,000 | $24,000 | 0.01% |